Related Articles
Real‑world data indicated that neoadjuvant chemotherapy alone was associated with a higher risk of tumor recurrence in high‑risk breast cancer subgroup patients
Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer
Strong impact of pathological node‑negative on long‑term overall survival of patients with triple‑negative breast cancer receiving neoadjuvant chemotherapy
Preoperative chemotherapy in colorectal cancer patients with synchronous liver metastasis
Clinical implications of tumor necrosis factor receptor 2 in breast cancer